Pcv44 - Effectiveness of Sacubitril/Valsartan Versus Enalapril in Reducing Mortality and Hospitalizations Costs From a Moroccan Hospital Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.591
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluating the Safety and Tolerability of Inpatient Sacubitril/Valsartan Initiation in a Community Hospital

Journal of Community Hospital Internal Medicine Perspectives
Internal Medicine
2020English

Cv3 - Cost-Effectiveness of Sacubitril/Valsartan in Germany: Applying the Efficiency Threshold

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure in Colombia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pcv86 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure Under the Brazilian Private Healthcare System Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Potential Markers of Sacubitril-Valsartan Tolerance

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Pharmacokinetics/Pharmacodynamics, Efficacy and Safety of Sacubitril/Valsartan Versus Enalapril in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction: Study Design and Rationale

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2016English

Sacubitril/Valsartan Use for the Hospitalist

American Journal of Hospital Medicine
2017English

Sacubitril/Valsartan: Beyond Natriuretic Peptides

Heart
Cardiovascular MedicineCardiology
2017English

Sacubitril-Valsartan in Heart Failure and Multimorbidity Patients

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy